| Literature DB >> 33363692 |
Aarushi Gupta1, Swati Sharma1, Abhenil Mittal2, Adarsh Barwad3, Sameer Rastogi2.
Abstract
Inflammatory myofibroblastic tumors (IMT) are rare soft tissue tumors of intermediate malignant potential with tendency for local recurrence. Although they can occur at all age groups, occurrence in infants is extremely unusual and their imaging characteristics are not well described. A 3-month-old female infant presented with gradually progressive abdominal distention without any fever or weight loss. She had a large ill-defined homogenous hypodense lesion of size 8.4 × 11.4 × 11.3 cm (APxTraxSag) in the abdomen showing mild delayed post contrast enhancement. She underwent exploratory laparotomy with gross total excision of mesenteric mass, histopathology of which was suggestive of IMT. She had recurrence within 6 months of complete resection with a well-defined heterogeneously enhancing lesion of size 1.8 × 1.8 × 2.3cm (APxTraxSag) in right paravesical region abutting the bladder without invasion with a similar lesion of size 4.4 × 2.1 × 3 cm (APxTraxSag) in left subdiaphragmatic region abutting superior surface of spleen (no invasion). Since, surgery in our patient would have entailed splenectomy and partial cystectomy, systemic therapy with ceritinib (anaplastic lymphoma kinase [ALK] inhibitor) was planned for her with which she had a near complete response after 2 months. A high index of suspicion is required to differentiate IMT from other common causes of mesenteric masses in children and role of radiologist is quintessential in this regard. Local recurrence with abutment but without invasion of surrounding structures points to the intermediate malignant pathology of IMT and may provide a clue to diagnosis. Systemic therapy is effective in patients who are ALK positive and destructive surgery should be avoided.Entities:
Keywords: ALK inhibitors; ALK, anaplastic lymphoma kinase; CT, computed tomography; Case report; DSRCT, desmoplastic small round cell tumor; IHC, immunohistochemistry; IMT, inflammatory myofibroblastic tumor; Infant; RMS, rhabdomyosarcoma; Recurrent mesenteric inflammatory myofibroblastic tumor; Systemic therapy; US, ultrasound
Year: 2020 PMID: 33363692 PMCID: PMC7753227 DOI: 10.1016/j.radcr.2020.12.027
Source DB: PubMed Journal: Radiol Case Rep ISSN: 1930-0433
Fig. 1(a and b) Preoperative CECT Abdomen Axial + Coronal images showing large hypodense mesenteric lesion with mild heterogenous post contrast enhancement displacing small bowel loops to left side and ascending colon posteriorly and abutting inferior surface of liver with no obvious infiltration.
Fig. 2(a) Low power photomicrograph of the tumor showing cells arranged in fascicles as well as haphazard pattern with edematous background and admixed inflammatory cells. (b) High power picture showing spindle cell population exhibiting myofibroblastic differentiation with mild to moderate nuclear pleomorphism, finely dispersed chromatin and moderate to abundant cytoplasm. The inflammatory cells are rich in plasma cells with lymphocytes and few eosinophils (H&E 200x). (c) Immunostain for ALK-1 showing nuclear reactivity in cells with myofibroblastic differentiation. (d) Immunostain for SMA showing cytoplasmic reactivity in cells with myofibroblastic differentiation.
Fig. 3(a and b) CECT abdomen at recurrence Axial + Coronal images showing heterogeneously enhancing lesion in left subdiaphragmatic region abutting superior surface of spleen with indentation and loss of fat plane. (c, d) CECT abdomen Axial + Coronal images showing heterogeneously enhancing lesion in right paravesical region indenting the right lateral wall of urinary bladder with loss of fat plane.
Fig. 4(a and b) Two moths post Ceritinib CECT Abdomen axial images showing complete resolution of right paravesical lesion and near complete resolution of left subdiaphragmatic lesion.